Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by All Cardiff Authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 130.

Ali, F.M., Salek, M.S., Finlay, A.Y. and Piguet, V. 2019. Validation of the electronic Psoriasis Area and Severity Index application: establishing measurement equivalence. Journal of The American Academy of Dermatology 81 (6) , pp. 1439-1441. 10.1016/j.jaad.2019.04.073
file

Bhatti, Zaheer Uddin, Finlay, Andrew Yule, Bolton, C. E., George, L., Halcox, Julian, Jones, S. M., Ketchell, Ian, Moore, R. H. and Salek, Mir-saeed 2014. Chronic disease influences over 40 major life-changing decisions (MLCDs): a qualitative study in dermatology and general medicine. Journal of the European Academy of Dermatology and Venereology 28 (10) , pp. 1344-1355. 10.1111/jdv.12289

Raja, Aditya, O'Neill, Claire, Joshi, Hrishikesh B. and Salek, Mir-saeed 2014. Re: Development of an instrument to assess the health related quality of life of kidney stone formers: K. L. Penniston and S. Y. Nakada J Urol 2013;189:921–930 [letter]. The Journal of Urology 192 (1) , pp. 280-281. 10.1016/j.juro.2014.01.112
file

Harun, Nur Ainita, Salek, Mir-saeed, Piguet, Vincent and Finlay, Andrew Yule 2014. The dermatology outpatient discharge decision: understanding a critical but neglected process. British Journal of Dermatology 170 (5) , pp. 1029-1038. 10.1111/bjd.12826

Golics, Catherine Jane, Basra, Mohammad Khurshid Azam, Finlay, Andrew Yule and Salek, Mir-saeed 2014. The development and validation of the Family Reported Outcome Measure (FROM-16)© to assess the impact of disease on the partner or family member. Quality of Life Research 23 (1) , pp. 317-326. 10.1007/s11136-013-0457-y

Allen, Nicola, Pichler, Franz, Wang, Tina, Patel, Sundip and Salek, Mir-saeed 2013. Development of archetypes for non-ranking classification and comparison of European National Health Technology Assessment systems. Health Policy 113 (3) , pp. 305-312. 10.1016/j.healthpol.2013.09.007

Basra, M. K. A., Gada, V., Ungaro, Shaun, Finlay, Andrew Yule and Salek, Mir-saeed 2013. Infants' Dermatitis Quality of Life Index: a decade of experience of validation and clinical application. British Journal of Dermatology 169 (4) , pp. 760-768. 10.1111/bjd.12563

Salek, Mir-saeed, Ngugi, N. M. and Ehling, M. 2013. The effectiveness of erythropoiesis stimulating agents (ESAs) in the treatment of myelodysplastic syndromes (MDS): systematic review and meta analysis [Abstract]. International Journal of Clinical Pharmacy 35 (5) , p. 1006. 10.1007/s11096-013-9801-0

Prinsen, C. A. C., de Korte, J., Augustin, M., Sampogna, F., Salek, Mir-saeed, Basra, M. K. A., Holm, E. A., Nijsten, T. E. C. and The EADV Taskforce on Quality of Life, 2013. Measurement of health-related quality of life in dermatological research and practice: outcome of the EADV Taskforce on Quality of Life. Journal of the European Academy of Dermatology and Venereology 27 (10) , pp. 1195-1203. 10.1111/jdv.12090

Salek, Mir-saeed, Dumrongprat, Kuntika and Nathisuwan, S. 2013. Cost-effectiveness of CYP2C9 and VKORC1 genetic testing to predict warfarin guided dose in Thai population [Abstract]. International Journal of Clinical Pharmacy 35 (5) , p. 1005. 10.1007/s11096-013-9801-0

Salek, Mir-saeed and Zawaneh, Yousef Z. 2013. Real world data in Europe: access, availability, and possible applications of population based cancer registries and diabetes databases [Abstract]. International Journal of Clinical Pharmacy 35 (5) , p. 970. 10.1007/s11096-013-9801-0

Salek, Mir-saeed and Seglah, Sabrina Elikem 2013. Critical evaluation of the national health insurance scheme in Ghana: the perspective of the stakeholders [Abstract]. International Journal of Clinical Pharmacy 35 (5) , p. 976. 10.1007/s11096-013-9801-0

Salek, Mir-saeed and Chong, Huey Yi 2013. Evaluation of the adequacy of patient-reported outcome measures used in atopic dermatitis: a systematic review [Abstract]. International Journal of Clinical Pharmacy 35 (5) , p. 969. 10.1007/s11096-013-9801-0

Golics, Catherine Jane, Basra, Mohammad K. A., Finlay, Andrew Yule and Salek, Mir-saeed 2013. The impact of disease on family members: a critical aspect of medical care. Journal of the Royal Society of Medicine 106 (10) , pp. 399-407. 10.1177/0141076812472616

Salek, Mir-saeed, Jung, S., Brincat-Ruffini, L. A., MacFarlane, L., Lewis-Jones, M. S., Basra, M. K. A. and Finlay, Andrew Yule 2013. Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012. British Journal of Dermatology 169 (4) , pp. 734-759. 10.1111/bjd.12437

Leong, James, McAuslane, Neil, Walker, Stuart and Salek, Mir-saeed 2013. Is there a need for a universal benefit-risk assessment framework for medicines? Regulatory and industry perspectives. Pharmacoepidemiology and Drug Safety 22 (9) , pp. 1004-1012. 10.1002/pds.3464

Dodington, Sean R., Basra, M. K. A., Finlay, Andrew Yule and Salek, Mir-saeed 2013. The Dermatitis Family Impact questionnaire: a review of its measurement properties and clinical application. British Journal of Dermatology 169 (1) , pp. 31-46. 10.1111/bjd.12232

Salek, Mir-saeed and Kamudoni, Paul 2013. Quality of life measurement in dermatology consultation: impact on patient reported outcomes. Giornale Italiano di Dermatologia e Venereologia 148 (3) , pp. 263-275.

Salek, Mir-saeed, Ionova, Tatyana and Oliva, Esther 2013. Patients' needs in hematology: whose perspectives? Haematologica 98 (6) , pp. 828-830. 10.3324/haematol.2013.090399

Bhatti, Zaheer Uddin, Salek, Mir-saeed, Bolton, Charlotte E., George, Lindsay, Halcox, Julian P. J., Jones, Sharon M., Ketchell, Ian R., Moore, Richard H., Sabit, Ramsey, Piguet, Vincent and Finlay, Andrew Yule 2013. The development and validation of the major life changing decision profile (MLCDP). Health and Quality of Life Outcomes 11 (1) , 78. 10.1186/1477-7525-11-78
file

Basra, Mohamed K. A., Finlay, Andrew Yule and Salek, Mir-saeed 2013. Development and validation of teenagers' Quality of Life (T-QoL(C)) index: A dermatology-specific measure for adolescents [Abstract]. Journal of Investigative Dermatology 133 (S1) , S95. 10.1038/jid.2013.98

Basra, Mohamed K. A., Salek, Mir-saeed and Finlay, Andrew Yule 2013. Minimal Clinically Important Difference (MCID) of the Dermatology Life Quality Index (DLQI) scores and responsiveness to change in inflammatory dermatoses [Abstract]. Journal of Investigative Dermatology 133 (S1) , S95. 10.1038/jid.2013.98

Deger, Melike, Eisterer, W., Kutikova, L. and Salek, Mir-saeed 2013. Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe. Supportive Care in Cancer 21 (2) , pp. 485-493. 10.1007/s00520-012-1538-0
file

Chomienne, Christine, Guenova, Margarita, Hagenbeek, Anton, Lacombe, Catherine, McCann, Shaun, Salek, Mir-saeed, Geissler, Jan and van der Beek, Ineke 2013. Quality of Life in hematology: European Hematology Association theme of the year ... and years to come. Haematologica 98 (1) , pp. 2-3. 10.3324/haematol.2012.080796

Golics, Catherine Jane, Basra, Mohammad, Salek, Mir-saeed and Finlay, Andrew Yule 2013. The impact of patients' chronic disease on family quality of life: an experience from 26 specialties. International Journal of General Medicine 6 , pp. 787-798. 10.2147/IJGM.S45156

Polek, Barbara, Roach, M. J., Andrews, William T., Ehling, Manfred and Salek, Mir-saeed 2013. Burden of Friedreich’s Ataxia to the patients and healthcare systems in the United States and Canada. Frontiers in Pharmacology 4 , 66. 10.3389/fphar.2013.00066
file

Salek, Mir-saeed, Schmidt-Rimpler, C., Wimberger, P., Gilet, H. and Parsons, S. L. 2012. Converting EORTC QOl-C30 Scores to Utility Values: Is it Plausible? [Abstract]. Value in Health 15 (7) , A478. 10.1016/j.jval.2012.08.1563

Salek, Mir-saeed, Deger, Melike, Wimberger, P., Gilet, H. and Parsons, S. L. 2012. Quality of Life in Patients With Malignant Ascites After Treatment With Catumaxomab: A Multicenter Phase II/III Study Comparing Paracentesis Plus Catumaxomab With Paracentesis Alone [Abstract]. Value in Health 15 (7) , A430-A431. 10.1016/j.jval.2012.08.2157

Finlay, Andrew Yule, Basra, Mohamed K. A., Piguet, Vincent and Salek, Mir-saeed 2012. Dermatology Life Quality Index (DLQI): A Paradigm Shift to Patient-Centered Outcomes [Letter]. Journal of Investigative Dermatology 132 (10) , pp. 2464-2465. 10.1038/jid.2012.147

Basra, Mohamed K. A., Pereira, F., Finlay, Andrew Yule, Piguet, Vincent and Salek, Mir-saeed 2012. EuroQol-5D (EQ-5D): its Use in Pharmacoeconomic Studies in Dermatology [Abstract]. Journal of Investigative Dermatology 132 (S2) , S72. 10.1038/jid.2012.300

Basra, Mohamed K. A., Cruz, P., Finlay, Andrew Yule, Piguet, Vincent and Salek, Mir-saeed 2012. The Dermatology Life Quality Index (DLQI) and EuroQol-5D (EQ-5D): is there a correlation between these two measures? [Abstract]. Journal of Investigative Dermatology 132 (S2) , S72. 10.1038/jid.2012.300

Kamudoni, Paul, Salek, Mir-saeed, Mueller, B. and Mueller, C. 2012. Hyperhidrosis Quality of Life Index (Hidroqol (c)): a novel patient reported outcome measure in hyperhidrosis [Abstract]. Journal of Investigative Dermatology 132 (S2) , S73. 10.1038/jid.2012.300

Golics, Catherine Jane, Basra, Mohamed K. A., Salek, Mir-saeed and Finlay, Andrew Yule 2012. The Family Reported Outcome Measure (c): initial validation of a generic QoL measure for family members of patients with chronic medical conditions [Abstract]. Journal of Investigative Dermatology 132 (S2) , S72. 10.1038/jid.2012.300

Pereira, F. R. A., Basra, Mohamed K. A., Finlay, Andrew Yule and Salek, Mir-saeed 2012. The Role of the EQ-5D in the Economic Evaluation of Dermatological Conditions and Therapies. Dermatology 225 (1) , pp. 45-53. 10.1159/000339865

Salek, Mir-saeed, Patel, Shriti and Pichler, F. 2012. Comparisons of pharmaceutical registration to reimbursement in the 30 European Economic area countries [Abstract]. International Journal of Clinical Pharmacy 34 (1) , p. 222. 10.1007/s11096-011-9602-2

Salek, Mir-saeed, Siyani, S., Basra, M. K. and Finlay, Andrew Yule 2012. The clinical and non-clinical factors influencing discharge decisions in dermatology: is there a need for discharge strategy? [Abstract]. International Journal of Clinical Pharmacy 34 (1) , pp. 178-179. 10.1007/s11096-011-9602-2

Salek, Mir-saeed, Mallia-Milanes, Andrea, McAuslane, Neil and Walker, Stuart 2012. Development and application of scorecards to assess the quality of a regulatory submission and its review. Drug Information Journal 46 (1) , pp. 73-83. 10.1177/0092861511427694

Al-Essa, Reem, Salek, Mir-saeed and Walker, Stuart 2012. Regulatory review process in the Gulf Cooperation Council states: similarities and differences. Drug Information Journal 46 (1) , pp. 65-72. 10.1177/0092861511427674

Al-Essa, Reem, Salek, Mir-saeed and Walker, Stuart 2012. An appraisal of good regulatory review practices in the Gulf Cooperation Council states. Drug Information Journal 46 (1) , pp. 57-64. 10.1177/0092861511427110

Salek, Mir-saeed, Jones, S., Rezaie, M., Davies, C., Mills, R. and Ketchell, Ian 2012. Do patient-reported outcomes have a role in the management of patients with cystic fibrosis? Frontiers in Pharmacology 3 (38) 10.3389/fphar.2012.00038
file

Finlay, Andrew Yule, Hajjaj, Fadi M., Salek, Mir-saeed and Basra, M. 2011. Non-clinical influences on decision taking in dermatology clinics [Abstract]. Journal of Investigative Dermatology 131 (S2) , S116-S117. 10.1038/jid.2011.216

Basra, M., Salek, Mir-saeed, Tanweer, Zahira, Fenech, Daniela, Howe, A., Mahbouba, Tina, Golics, Catherine Jane, Piguet, Vincent and Finlay, Andrew Yule 2011. Refinement and Validation of Teenager's Quality of Life Questionnaire (T-QoL) [Abstract]. Journal of Investigative Dermatology 131 (S2) , S50. 10.1038/jid.2011.214

Basra, M., Siyani, Seetal, Salek, Mir-saeed, Piguet, Vincent and Finlay, Andrew Yule 2011. A Qualitative Investigation into the Factors Influencing Discharge Decisions in Dermatology [Abstract]. Journal of Investigative Dermatology 131 (S2) , S50. 10.1038/jid.2011.214

Basra, M., Zammit, Anne Marie, Salek, Mir-saeed and Finlay, Andrew Yule 2011. Application of Rasch Analysis to Psoriasis Family Index (PFI) - a Novel Psoriasis-Specific Quality of Life Instrument for Family Members and Partners of Psoriasis Patients [Abstract]. Journal of Investigative Dermatology 131 (S2) , S49. 10.1038/jid.2011.214

Golics, Catherine Jane, Basra, M., Salek, Mir-saeed and Finlay, Andrew Yule 2011. Diseases profoundly affect the Quality of Life of family members of patients [Abstract]. Journal of Investigative Dermatology 131 (S2) , S39. 10.1038/jid.2011.214

Salek, Mir-saeed, Abdulla, A. and Raasch, R. 2011. How far are the pharmacists in North Carolina prepared to extend their role in immunisation? [Abstract]. International Journal of Clinical Pharmacy 33 (2) , pp. 431-432. 10.1007/s11096-011-9481-6

Salek, Mir-saeed, Fairfax, M. and Basra, M. 2011. Psychometric evaluation of a family psoriasis specific quality of life instrument [Abstract]. International Journal of Clinical Pharmacy 33 (2) , pp. 409-410. 10.1007/s11096-011-9481-6

Salek, Mir-saeed, Allen, N. and Pichler, F. 2011. Categorisation of HTA agencies and their decision-making systems from regulatory approval to reimbursement [Abstract]. International Journal of Clinical Pharmacy 33 (2) , p. 400. 10.1007/s11096-011-9481-6

Salek, Mir-saeed, McKnight, R. and Basra, M. 2011. How much money and time are the family of dermatology patients willing to trade off for improved quality of life? [Abstract]. International Journal of Clinical Pharmacy 33 (2) , pp. 399-400. 10.1007/s11096-011-9481-6

Bhatti, Zaheer Uddin, Salek, Mir-saeed and Finlay, Andrew Yule 2011. Major life changing decisions and cumulative life course impairment [Letter]. Journal Of The European Academy Of Dermatology & Venereology 25 (2) , pp. 245-246. 10.1111/j.1468-3083.2010.03930.x

Bhatti, Zaheer Uddin, Salek, Mir-saeed and Finlay, Andrew Yule 2011. Chronic diseases influence major life changing decisions: a new domain in quality of life research. Journal of the Royal Society of Medicine 104 (6) , pp. 241-250. 10.1258/jrsm.2011.110010

Finlay, Andrew Yule, Hajjaj, Fadi M., Basra, M. K. A. and Salek, Mir-saeed 2011. Non-clinical influences in the dermatology consultation: the doctor's perspective and the challenge to evidence based practice [Abstract]. Acta Dermato-Venereologica 91 (2) , p. 224.

Salek, Mir-saeed 2011. Potential long term benefits from early assessment of disease impact on QoL in routine practice [Abstract]. Acta Dermato-Venereologica 91 (2) , p. 220.

Basra, Muhammed A. K., Salek, Mir-saeed, Fenech, D., Howe, A., Mahbouba, Tina, Golics, Catherine Jane and Finlay, Andrew Yule 2011. Measuring skin disease in adolescence: bridging the gap in quality of life assessment [Abstract]. Acta Dermato-Venereologica 91 (2) , p. 219.

Valentin, M., Neises, G. and Salek, Mir-saeed 2011. Did Iqwig's drug appraisals in connection with G-BA'S directives change prescribing behavior of German physicians? Value in Health 14 (7) , A351. 10.1016/j.jval.2011.08.651

Bhatti, Zaheer Uddin, Salek, Mir-saeed and Finlay, Andrew Yule 2011. The influence of skin disease on major life changing decisions [Abstract]. Acta Dermato-Venereologica 91 (2) , pp. 221-222.

Bhatti, Zaheer Uddin, Salek, Mir-saeed and Finlay, Andrew Yule 2011. Development of the Major Life Changing Decisions Profile: a novel approach to measure the long-term impact of disease [Abstract]. British Journal of Dermatology 165 (S1) , p. 52. 10.1111/j.1365-2133.2011.10277.x

Golics, Catherine Jane, Basra, M. K. A., Salek, Mir-saeed and Finlay, Andrew Yule 2011. The impact of disease on the lives of family members [Abstract]. Acta Dermato-Venereologica 91 (2) , pp. 219-220.

Hajjaj, Fadi M, Salek, Mir-saeed, Basra, M. K. A. and Finlay, Andrew Yule 2010. Nonclinical influences, beyond diagnosis and severity, on clinical decision making in dermatology: understanding the gap between guidelines and practice. British Journal of Dermatology 163 (4) , pp. 789-799. 10.1111/j.1365-2133.2010.09868.x

Basra, M. K., Williams, Owain, McKnight, Rhiannon and Salek, Mir-saeed 2010. A Preference Based Approach to Assess Quality of Life of Family Members of Patients with Inflammatory Skin Diseases [Abstract]. Journal of Investigative Dermatology 130 (S2) , S71. 10.1038/jid.2010.238

Bhatti, Zaheer Uddin, Salek, Mir-saeed and Finlay, Andrew Yule 2010. The influence of chronic skin diseases on major life-changing decisions as a parameter for the assessment of long-term impact [Abstract]. British Journal of Dermatology 163 (S1) , pp. 39-40. 10.1111/j.1365-2133.2010.09728.x

Hajjaj, F., Salek, Mir-saeed, Basra, M. K. A. and Finlay, Andrew Yule 2010. Nonclinical influences in dermatology decision making: a study of clinicians' perspective [Abstract]. British Journal of Dermatology 163 (S1) , pp. 44-45. 10.1111/j.1365-2133.2010.09728.x

Basra, M. K. A., Camilleri, L., Salek, Mir-saeed and Finlay, Andrew Yule 2010. Strengthening the Dermatology Life Quality Index's clinical meaning: minimal clinically important difference of the scores [Abstract]. British Journal of Dermatology 163 (S1) , p. 41. 10.1111/j.1365-2133.2010.09728.x

Hajjaj, F. M., Salek, Mir-saeed, Basra, M. K. A. and Finlay, Andrew Yule 2010. Non-clinical influences on clinical decision-making: a major challenge to evidence-based practice. Journal of the Royal Society of Medicine 103 (5) , pp. 178-187. 10.1258/jrsm.2010.100104

Salek, Mir-saeed, Sanghvi, S., Rodgers, J. and Montague, D. 2010. Evaluation of the use and efficacy of heparin nomograms in a university-teaching hospital in North Carolina [Abstract]. Pharmacy World and Science 32 (2) , p. 263. 10.1007/s11096-010-9378-9

Salek, Mir-saeed, Modi, A, Hansen, R. A. and Wei, D. 2010. Reducing repeat medication errors in nursing homes [Abstract]. Pharmacy World and Science 32 (2) , pp. 242-243. 10.1007/s11096-010-9378-9

Salek, Mir-saeed, Mahbouba, T., Basra, M., Golicks, C. and Finlay, Andrew 2010. Adolescents with skin diseases: the forgotten group [Abstract]. Pharmacy World and Science 32 (2) , pp. 240-241. 10.1007/s11096-010-9378-9

Salek, Mir-saeed, Sturkey, R., Basra, M. and Finlay, Andrew Yule 2010. Assessment of the clinical meaningfulness of change in dermatology life quality index scores [Abstract]. Pharmacy World and Science 32 (2) , p. 236. 10.1007/s11096-010-9378-9

Hajjaj, F. M., Salek, Mir-saeed, Basra, M and Finlay, Andrew Yule 2010. Clinical decision making in dermatology: observation of consultations and the patients' perspectives. Dermatology 221 (4) , pp. 331-341. 10.1159/000320124

Salek, Mir-saeed, Kamau, P., McAuslane, N, Pichler, F. and Walker, Stuart 2010. Is simultaneous submission and regulatory approval a reality towards faster patient access to medicines in the ICH region and beyond? [Abstract]. Pharmacy World and Science 32 (2) , pp. 218-219. 10.1007/s11096-010-9378-9

Golics, Catherine Jane, Basra, M. K. A., Finlay, Andrew Yule and Salek, Mir-saeed 2009. Adolescents with skin disease have specific Quality of Life issues. Dermatology 218 (4) , pp. 357-366. 10.1159/000205524

Tlusta, Eva, Zarubova, Jana, Simko, Julius, Hojdikova, Helena, Salek, Mir-saeed and Vlcek, Jiri 2009. Clinical and demographic characteristics predicting QOL in patients with epilepsy in the Czech Republic: how this can influence practice. Seizure 18 (2) , pp. 85-89. 10.1016/j.seizure.2008.06.006

Almotiri, Badreea and Salek, Mir-saeed 2009. Health care professionals attitude towards noncompliance with drug treatment [Abstract]. Pharmacy World & Science 31 (2) , p. 247. 10.1007/s11096-008-9274-8

Bhatti, Zaheer Uddin, Finlay, Andrew Yule, Salek, Sam, Ketchell, Ian and Bolton, Charlotte Emma 2009. Chronic respiratory diseases strongly influence major life-changing decisions. Thorax 64 (Supp.4) , A113. 10.1136/thx.2009.127159m

Hajjaj, Fadi M., Basra, M. K., Salek, Mir-saeed and Finlay, Andrew Yule 2009. Nonclinical influences on clinical decision making in dermatology [Abstract]. British Journal of Dermatology 161 (S1) , p. 59. 10.1111/j.1365-2133.2009.09126.x

Salek, Mir-saeed, Golicks, C., Basra, M. and Finlay, Andrew Yule 2009. What are the health-related quality-of-life issues in adolescents with skin disease? Do they require special consideration [Abstract]. Pharmacy World & Science 31 (2) , pp. 328-329. 10.1007/s11096-008-9274-8

Salek, Mir-saeed, Khalaf, M. and Ives, T. 2009. Patterns of obtaining prescribed medicines for chronic diseases among Medicaid patients [Abstract]. Pharmacy World & Science 31 (2) , pp. 311-312. 10.1007/s11096-008-9274-8

Salek, Mir-saeed, Loh, E. A. T., McAuslane, N., Read, K. and Walker, Stuart 2009. Factors influencing delays of pharmaceutical product registration in new markets: a global concern [Abstract]. Pharmacy World & Science 31 (2) , pp. 277-278. 10.1007/s11096-008-9274-8

Salek, Mir-saeed, Rehman, L. and Eckel, S. 2009. The impact of a reduction in the number of automated alerts on pharmacist's response to drug-drug interactions [Abstract]. Pharmacy World & Science 31 (2) , p. 249. 10.1007/s11096-008-9274-8

Salek, Mir-saeed, Wellum, A., Rogers, J. E. and MacKay, J. 2009. Is the dose escalation of statins an appropriate management strategy for lowering low-density lipoprotein? [Abstract]. Pharmacy World & Science 31 (2) , p. 329. 10.1007/s11096-008-9274-8

Walker, S., McAuslane, N., Liberti, L. and Salek, Sam 2009. Measuring Benefit and Balancing Risk: Strategies for the Benefit-Risk Assessment of New Medicines in a Risk-Averse Environment. Clinical Pharmacology and Therapeutics 85 (3) , pp. 241-246. 10.1038/clpt.2008.277

Walker, S., McAuslane, N., Liberti, L. and Salek, Mir-saeed 2009. Measuring benefit and balancing risk: strategies for the benefit–risk assessment of new medicines in a risk-averse environment. Clinical Pharmacology and Therapeutics 85 (3) , pp. 241-246. 10.1038/clpt.2008.277

Basra, M. K., Sturkey, Rebeca L., Salek, Mir-saeed and Finlay, Andrew Yule 2009. Dermatology Life Quality Index: measuring the change in scores and its clinical meaningfulness [Abstract]. Journal of Investigative Dermatology 129 (S2) , S30. 10.1038/jid.2009.232

Bhatti, Zaheer Uddin, Finlay, Andrew Yule and Salek, Mir-saeed 2009. Chronic skin diseases influence major life-changing decisions: a new frontier in health outcome research [Abstract]. British Journal of Dermatology 161 (S1) , pp. 58-59.

Salek, Mir-saeed, Watson, S. and Ketchell, Ian 2009. Health-related quality of life in adult cystic fibrosis: development of a new measure [Abstract]. Pharmacy World & Science 31 (2) , pp. 250-251. 10.1007/s11096-008-9274-8

Salek, Sam, Gill, N., Gates, B., Rice, L. and Weeks, D. 2008. Evaluation of the effectiveness of sliding scale insulin for glycemic control in the home care setting [Abstract]. Pharmacy World & Science 30 (5) , p. 709. 10.1007/s11096-008-9226-3

Salek, Sam, Morgan, L., McAuslane, N., Read, K. and Walker, Stuart 2008. Companies submission strategies and regulatory approval times greatly influence patient access to medicine [Abstract]. Pharmacy World and Science 30 (5) , p. 720. 10.1007/s11096-008-9226-3

Salek, Sam, Mallia-Milanes, A., McAuslane, N. and Walker, Stuart 2008. Can systematic use of scorecards be of value in the evaluation of the quality of industry submissions and their regulatory review? [Abstract]. Pharmacy World and Science 30 (5) , p. 721. 10.1007/s11096-008-9226-3

Basra, M. K. A., Edmunds, O., Salek, Mir-saeed and Finlay, Andrew Yule 2008. Measurement of family impact of skin disease: further validation of the Family Dermatology Life Quality Index (FDLQI). Journal of the European Academy of Dermatology and Venereology 22 (7) , pp. 813-821. 10.1111/j.1468-3083.2008.02593.x

Hajjaj, F. M., Basra, M., Salek, Sam and Finlay, Andrew Yule 2008. Influences on clinical decision-making in dermatology outpatient clinics [Abstract]. British Journal of Dermatology 159 (S1) , pp. 49-50. 10.1111/j.1365-2133.2008.08538.x

Basra, M. K. A., Fenech, R., Gatt, R. M., Salek, Sam and Finlay, Andrew Yule 2008. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. British Journal of Dermatology 159 (5) , pp. 997-1035. 10.1111/j.1365-2133.2008.08832.x

Salek, Sam, Lewis-Smith, R. E., Ives, T. J. and Rake, K. M. 2008. How prevalent are opioid misuse and affective disorders in patients with fibromyalgia? Pharmacy World and Science 30 (5) , pp. 719-720.

Salek, Sam, Patel, J. and Schwartz, C. 2008. Evaluation of a rapid streptococcus testing service in the community pharmacy. Pharmacy World and Science 30 (5) , pp. 707-708.

Davies, Emily, Patel, C., Salek, Mir-saeed and Finlay, Andrew Yule 2008. Does ad hoc quality-of-life discussion in inflammatory skin disease consultations reflect standardized patient-reported outcomes? Clinical and Experimental Dermatology 33 (1) , pp. 16-21. 10.1111/j.1365-2230.2007.02557.x

Hajjaj, F. M., Basra, M., Salek, Sam and Finlay, Andrew Yule 2008. Clinical decision-making in dermatology: the role of clinical and non clinical factors [abstract]. Journal Of Investigative Dermatology 128 (10) , 2550 -2550. 10.1038/jid.2008.267

Salek, Sam, Chauhan, A., Hirako, M., McAuslane, N. and Walker, Stuart 2007. Does the global increase in post-marketing commitment ensure faster patient access to novel medicines? [Abstract]. Pharmacy World and Science 29 (5) , p. 449. 10.1007/s11096-007-9098-y

Mussen, Filip, Salek, Mir-saeed and Walker, Stuart 2007. A quantitative approach to benefit-risk assessment of medicines - part 1: The development of a new model using multi-criteria decision analysis. Pharmacoepidemiology and Drug Safety 16 (S1) , s2-s15. 10.1002/pds.1435

Salek, Sam, Shafie, A., Evans, R., Freedman, A., Birley, H., Browning, M. and Cohen, D. 2007. The case for HRQoL assessment: key to successful HIV treatment. Pharmacy World & Science 29 (5) , p. 491.

Salek, Sam, Davies, E., Patel, Chirag Bipinbhai and Finlay, Andrew Yule 2007. Health related quality of life (HRQoL) discussion in consultations: a key to successful treatment outcomes. Pharmacy World & Science 29 (5) , pp. 454-455.

Salek, Sam, Suntharasaj, S. and Suntharasaj, T. 2007. Conceptualisation of a menopause-specific quality of life profile. Pharmacy World & Science 29 (5) , p. 495.

Salek, Sam, Samson, R. and Gilbertson, J. 2007. Optimisation of discharge communication: a key to successful outcome. Pharmacy World & Science 29 (5) , pp. 474-475.

Salek, Sam, Shafie, A., Evans, R., Freedman, A., Birley, H., Browning, M. and Cohen, D. 2007. Can systematic assessment of patients' quality of life influence optimisation of HIV treatment? Pharmacy World & Science 29 (5) , pp. 490-491.

Tlusta, E., Kubena, A., Salek, Sam and Vlcek, J. 2007. Psychometric properties of the Czech version of the Quality of Life in Epilepsy Inventory (QOLIE-31). Epilepsy & Behavior 10 (3) , pp. 407-411. 10.1016/j.yebeh.2007.01.002

Salek, Sam, Roberts, Alaw and Finlay, Andrew Yule 2007. The practical reality of using a patient-reported outcome measure in a routine dermatology clinic. Dermatology 215 (4) , pp. 315-319. 10.1159/000107625

Davies, E., Patel, Chirag, Salek, Mir-saeed and Finlay, Andrew Yule 2006. Quality of life discussion and patient satisfaction in inflammatory skin disease consultations [Abstract]. Journal of the American Academy of Dermatology 54 (3S) , AB120. 10.1016/j.jaad.2005.11.493

Dixon, S., Walker, M. and Salek, Mir-saeed 2006. Incorporating carer effects into economic evaluation. PharmacoEconomics 24 (1) , pp. 43-53.

Shafie, A. A., Salek, Mir-saeed, Evans, R. H., Freedman, Andrew Robert, Birley, H., Browning, M. and Cohen, D. 2005. Self assessed health-related quality of life among HIV patient in UK [Abstract]. Value in Health 8 (6) , A62. 10.1016/S1098-3015(10)67329-9

Katugampola, Ruwani, Thomas, C. L., Hongbo, Yan, Salek, Mir-saeed and Finlay, Andrew Yule 2005. Psoriasis decision taking and the dermatology life quality index bands [Abstract]. British Journal of Dermatology 153 (2) , pp. 475-476. 10.1111/j.1365-2133.2005.06872.x

Al-Motarreb, Ahmed, Briancon, S, Al-Jaber, N, Al-Adhi, B., Al-Jailani, F., Salek, Mir-saeed and Broadley, Kenneth John 2005. Khat chewing is a risk factor for acute myocardial infarction: a case control study. British Journal of Clinical Pharmacology 59 (5) , pp. 574-581. 10.1111/j.1365-2125.2005.02358.x

Hongbo, Yan, Thomas, Charles L., Harrison, Michael A., Salek, Mir-saeed and Finlay, Andrew Yule 2005. Translating the science of quality of life into practice: what do Dermatology Life Quality Index scores mean? Journal of Investigative Dermatology 125 (4) , pp. 659-664. 10.1111/j.0022-202X.2005.23621.x

Hongbo, Yan, Thomas, C. L., Harrison, M. A., Salek, Mir-saeed and Finlay, Andrew Yule 2004. Translating the science of quality of life into practice: what do Dermatology Life Quality Index scores mean? [Abstract]. British Journal of Dermatology 151 (S68) , pp. 45-46. 10.1111/j.1365-2133.2004.05948.x

Salek, Mir-saeed, Finlay, AY, Lewis, James and Sumner, MJ 2004. Quality of life improvement in treatment of psoriasis with intermittent short course Cyclosporin (Neoral®). Quality of Life Research 13 (1) , pp. 91-95. 10.1023/B:QURE.0000015293.69661.ff

Al-Mohammadi, A, Salek, Mir-saeed, Maughan, Timothy Stanley, Nicholls, P. J. and Mason, Malcolm David 2003. The impact of routine assessment of information needs on patient outcomes. Psycho-oncology 12 (6) , p. 641. 10.1002/pon.752

Finlay, Ilora Gillian, Pratheepawanit, N. and Salek, Mir-saeed 2003. Monitoring self-reported quality-of-life among patients attending a palliative medicine outpatient clinic [Letter]. Palliative Medicine 17 (1) , pp. 83-84. 10.1191/0269216303pm663xx

Finlay, Andrew Yule, Salek, Mir-saeed and Haney, J. 2003. Intramuscular alefacept improves health-related quality of life in patients with chronic plaque psoriasis. Dermatology 206 (4) , pp. 307-315. 10.1159/000069942

Pratheepawanit, N., Salek, Mir-saeed and Finlay, Ilora Gillian 1999. The applicability of quality-of-life assessment in palliative care: comparing two quality-of-life measures. Palliative Medicine 13 (4) , pp. 325-334. 10.1191/026921699670560921

Almuzaini, A. S, Salek, Mir-saeed, Nicholls, P. J. and Alomar, B. A. 1998. The attitude of health care professionals toward the availability of hospice services for cancer patients and their carers in Saudi Arabia. Palliative Medicine 12 (5) , pp. 365-373. 10.1191/026921698667234126

Salek, Mir-saeed, Finlay, Andrew Yule and Sumner, M. 1997. Long-term cyclosporin treatment improves quality of life in eczema [Abstract]. Quality of Life Research 6 (7-8) , 334.

Salek, Mir-saeed, Jones, H. and Coles, G. A. 1997. Assessment of quality of life in renal patients using the Renal Quality of Life Profile - a validation study [Abstract]. Quality of Life Research 6 (7-8) , p. 714. 10.1023/A:1018424519364

Salek, Mir-saeed, Finlay, Andrew Yule and Sumner, M. J. 1997. Impact of intermittent short course cyclosporin therapy on quality of life of patients with psoriasis [Abstract]. Quality of Life Research 6 (7-8) , 335.

Salek, Mir-saeed 1997. Compendium of quality of life instruments [Abstract]. Quality of Life Research 6 (7-8) , pp. 713-714.

Blackford, S., Roberts, D., Salek, Mir-saeed and Finlay, Andrew Yule 1996. Basal cell carcinomas cause little handicap. Quality of Life Research 5 (2) , pp. 191-194.

Salek, Mir-saeed, Khan, G. and Finlay, Andrew Yule 1996. Questionnaire techniques in assessing acne handicap: reliability and validity study. Quality of Life Research 5 (1) , pp. 131-138.

Berth-Jones, J., Finlay, Andrew Yule, Zaki, I., Tan, B., Goodyear, H., Lewis-Jones, S, Cork, M. J., Bleehen, S. S, Salek, Mir-saeed, Allen, B. R., Friedmann, P., Harper, J., Camp, R. D. R., Smith, S. and Graham-Brown, R. A. C. 1996. Cyclosporine in severe childhood atopic dermatitis: a multicenter study. Journal of the American Academy of Dermatology 34 (6) , pp. 1016-1021. 10.1016/S0190-9622(96)90281-9,

Salek, Mir-saeed, Finlay, Andrew Yule, Luscombe, David Keith, Allen, B. R., Berth-Jones, J., Camp, R. D. R., Graham-Brown, R. A. C., Khan, G. K., Marks, R., Motley, R. J., Ross, J. S. and Sowden, Jonathan 1993. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. British Journal of Dermatology 129 (4) , pp. 422-430. 10.1111/j.1365-2133.1993.tb03170.x

Salek, Mir-saeed 1993. Health-related quality of life measurement:a new challenge for pharmacy practitioners. Journal of Pharmacy and Pharmacology 45 (S1) , pp. 387-392.

Sowden, J. M., Berth-Jones, J., Ross, J. S., Motley, R. J., Marks, R., Finlay, Andrew Yule, Salek, Mir-saeed, Graham-Brown, R. A. C, Allen, B. R and Camp, R. D. R 1991. Double-blind, controlled, crossover study of cyclosporine in adults with severe refractory atopic-dermatitis. The Lancet 338 (8760) , pp. 137-140.

Finlay, Andrew Yule, Khan, G. K., Luscombe, David Keith and Salek, Mir-saeed 1990. Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis. British Journal of Dermatology 123 (6) , pp. 751-756. 10.1111/j.1365-2133.1990.tb04192.x

Salek, Mir-saeed, Finlay, Andrew Yule, Kahn, G. K. and Luscombe, David Keith 1989. Quality of life measurement in patients with psoriasis. Presented at: 18th European Symposium on Clinical Pharmacy, Nijmegen, Netherlands, 1989. Published in: Muller, N. F. and Hekster, Y. A. eds. Rational Use of Drugs: Proceedings of the 18th European Symposium on Clinical Pharmacy, Nijmegen, 1989. Progress in Clinical Pharmacy The Hague: Amsterdam Medical Press, SDU Publishers, pp. 255-259.

Salek, Mir-saeed, Luscombe, David Keith, Walker, Stuart, Grob, P. R., Vandenburg, M. J. and Lewis, Malcolm John 1988. Cardiovascular-disease and quality of life [Abstract]. British Journal of Clinical Pharmacology 26 (5) , 628P-628P.

This list was generated on Tue Aug 4 06:45:55 2020 BST.